VentriJect represented the team at the longevity conference in Provence.

At VentriJect, we want to change how we work with cardiorespiratory fitness. Cardiorespiratory fitness, also expressed as VO2max, is the strongest indicator of health, according to several studies, and even small improvements in VO2max can mean a significant health improvement. Unfortunately, evaluating cardiorespiratory fitness today can be cumbersome, time-consuming, expensive and dependent on highly-trained staff. At VentriJect we want to change that. Introducing the Seismofit - a radical new approach to evaluating cardiorespiratory fitness. With high accuracy, no training required, and extreme ease of use, we can estimate your VO2max in less than 3 minutes - a fraction of the time used with other approaches. This clinical-validated and patented technology is unique and a true game-changer, and will provide significant value to the patients and the healthcare practitioners. VentriJect was established as a spin-out from a leading research center in cardiology at Aalborg University in 2018 and is situated in Hellerup near Copenhagen, Denmark. US disclaimer: The application provided by VentriJect in the United States of America is considered a low risk wellness device to promote a healthy lifestyle (general wellness) and does not provide any reference to diseases or conditions. This type of device does not require registration with the US FDA per the Guidance on General Wellness: Policy for Low Risk Devices issued January 6, 2026. Information in this presentation or provided by the VentriJect application is not intended to be a substitute for professional medical advice, diagnosis or treatment. Talk with your doctor about diagnosis and treatment information. VentriJect and its representatives make no guarantees or promises regarding the results you receive from the use of the application.

Founded 2018